73 related articles for article (PubMed ID: 1768559)
21. Pharmacokinetics, bioavailability and effects on electrocardiographic parameters of oral fludarabine phosphate.
Yin W; Karyagina EV; Lundberg AS; Greenblatt DJ; Lister-James J
Biopharm Drug Dispos; 2010 Jan; 31(1):72-81. PubMed ID: 19862681
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and Pharmacodynamics of procyclidine in man.
Whiteman PD; Fowle AS; Hamilton MJ; Peck AW; Bye A; Dean K; Webster A
Eur J Clin Pharmacol; 1985; 28(1):73-8. PubMed ID: 3987788
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative, bromerguride.
Krause W; Sauerbrey N; Gräf KJ
Eur J Clin Pharmacol; 1986; 31(2):165-8. PubMed ID: 3803415
[TBL] [Abstract][Full Text] [Related]
24. The effect of ageing on the hepatic clearance of propranolol.
Castleden CM; George CF
Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
[TBL] [Abstract][Full Text] [Related]
25. Influence of cytochrome P450 genotype on the plasma disposition of prochlorperazine metabolites and their relationships with clinical responses in cancer patients.
Tashiro M; Naito T; Kagawa Y; Kawakami J
Ann Clin Biochem; 2018 May; 55(3):385-393. PubMed ID: 28853295
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of indoramin and its metabolite 6-hydroxyindoramin after single and multiple doses to cirrhotic liver patients.
Neumann G; Wilke G; Reimold WV; Pierce DM; Giesing M
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S20-4. PubMed ID: 2423791
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of chlorpromazine after single and chronic dosage.
Dahl SG; Strandjord RE
Clin Pharmacol Ther; 1977 Apr; 21(4):437-48. PubMed ID: 849674
[TBL] [Abstract][Full Text] [Related]
28. [Reactions of the extrapyramidal nervous systems induced by prochlorperazine].
LOFGREN CG; OLAFSSON O
Sven Lakartidn; 1962 Apr; 59():1239-40. PubMed ID: 14466270
[No Abstract] [Full Text] [Related]
29. [Study of the effect of prochlorpemazine on cerebral electrogenesis].
VALLADE L; MILETTO G; BARRABINO JH; MERLIN L
Ann Med Psychol (Paris); 1959 Nov; 117(2)():701-10. PubMed ID: 13840869
[No Abstract] [Full Text] [Related]
30. Simultaneous determination of prochlorperazine and its metabolites in human plasma using isocratic liquid chromatography tandem mass spectrometry.
Tashiro M; Naito T; Kagawa Y; Kawakami J
Biomed Chromatogr; 2012 Jun; 26(6):754-60. PubMed ID: 21990013
[TBL] [Abstract][Full Text] [Related]
31. Treating nausea and vomiting in palliative care: a review.
Glare P; Miller J; Nikolova T; Tickoo R
Clin Interv Aging; 2011; 6():243-59. PubMed ID: 21966219
[TBL] [Abstract][Full Text] [Related]
32. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache.
Hoy SM; Scott LJ
CNS Drugs; 2011 Apr; 25(4):343-58. PubMed ID: 21425885
[TBL] [Abstract][Full Text] [Related]
33. Treatment of nausea and vomiting in terminally ill cancer patients.
Glare PA; Dunwoodie D; Clark K; Ward A; Yates P; Ryan S; Hardy JR
Drugs; 2008; 68(18):2575-90. PubMed ID: 19093700
[TBL] [Abstract][Full Text] [Related]
34. The pharmacokinetics and effects of prochlorperazine in elderly female volunteers.
Isah AO; Rawlins MD; Bateman DN
Age Ageing; 1992 Jan; 21(1):27-31. PubMed ID: 1553856
[TBL] [Abstract][Full Text] [Related]
35. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
37. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
Finn A; Collins J; Voyksner R; Lindley C
J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
[TBL] [Abstract][Full Text] [Related]
38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology of prochlorperazine in healthy young males.
Isah AO; Rawlins MD; Bateman DN
Br J Clin Pharmacol; 1991 Dec; 32(6):677-84. PubMed ID: 1768559
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
